Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · August 11, 2021

DOAC vs Aspirin for Cerebrovascular Events in Patients Undergoing Ventricular Tachycardia Ablation

JACC: Clinical Electrophysiology


Additional Info

Disclosure statements are available on the authors' profiles:

JACC: Clinical Electrophysiology
SafeTy and Efficacy of Direct Oral Anticoagulant Versus Aspirin for Reduction Of RisK of CErebrovascular Events in Patients Undergoing Ventricular Tachycardia Ablation (STROKE-VT)
JACC Clin Electrophysiol 2021 Aug 29;[EPub Ahead of Print], D Lakkireddy, J Shenthar, J Garg, et al

Further Reading